Related Experiment Video

Updated: May 7, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.7K

FTY720 for cancer therapy (Review)

Li Zhang1, Han-Dong Wang, Xiang-Jun Ji

  • 1Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, P.R. China.

Oncology Reports
|October 9, 2013
PubMed

Insights

FTY720, an FDA-approved multiple sclerosis drug, also demonstrates preclinical antitumor effects. Unphosphorylated FTY720 targets cancer via S1PR-independent mechanisms, distinct from its immunosuppressive action.

Area of Science:

  • Pharmacology
  • Immunology
  • Oncology

Background:

  • 2-Amino-2-[2-(4-octylphenyl)]-1,3-propanediol hydrochloride (FTY720) is an FDA-approved immunosuppressant for multiple sclerosis.
  • Its mechanism involves activating sphingosine-1-phosphate receptors (S1PRs).
  • FTY720 exhibits preclinical antitumor efficacy in various cancer models.

Purpose of the Study:

  • To review the therapeutic applications of FTY720 in cancer treatment.
  • To explore the molecular targets of the unphosphorylated form of FTY720 in cancer therapy.

Main Methods:

  • Literature review of FTY720 in cancer therapy.
  • Analysis of S1PR-independent mechanisms of FTY720's cytotoxic effects.

Main Results:

  • FTY720 demonstrates preclinical antitumor activity.
  • Cytotoxic effects of FTY720 in cancer often do not require phosphorylation.
  • These S1PR-independent mechanisms differ from its immunosuppressive properties.

Conclusions:

  • FTY720 possesses dual therapeutic potential in multiple sclerosis and cancer.
  • Understanding S1PR-independent pathways is crucial for FTY720's anticancer applications.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.1K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Cancer Therapies02:49

Cancer Therapies

2.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K